- Home
- MMSI vs VKTX Comparison
MMSI vs VKTX Comparison
Compare MMSI & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MMSI | VKTX |
|---|---|---|
| Founded | 1987 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.0B |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MMSI | VKTX |
|---|---|---|
| Price | $87.39 | $41.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $98.88 | $95.86 |
| AVG Volume (30 Days) | 456.0K | ★ 3.5M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 4.93 | N/A |
| EPS | ★ 1.33 | N/A |
| Revenue | ★ $1,515,906,000.00 | N/A |
| Revenue This Year | $8.85 | N/A |
| Revenue Next Year | $5.88 | N/A |
| P/E Ratio | $65.61 | ★ N/A |
| Revenue Growth | ★ 11.75 | N/A |
| 52 Week Low | $59.74 | $24.88 |
| 52 Week High | $94.75 | $43.15 |
Technical Indicators
Market Signals| Indicator | MMSI | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 50.20 | 73.16 |
| Support Level | $85.19 | $28.50 |
| Resistance Level | $92.22 | $42.79 |
| Average True Range (ATR) | 1.98 | 1.65 |
| MACD | -0.44 | 0.97 |
| Stochastic Oscillator | 37.35 | 96.80 |
Price Performance
Historical ComparisonAbout MMSI Merit Medical Systems Inc.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.